skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
05/24/2022
Application #:
16098983
Filing Dt:
11/05/2018
Publication #:
Pub Dt:
05/23/2019
PCT #:
US1733042
Inventors:
Sarah C. GARRETT-THOMSON, Steven C. ALMO, Ronald D. SEIDEL III
Title:
VARIANT PD-L1 POLYPEPTIDES, T-CELL MODULATORY MULTIMERIC POLYPEPTIDES, AND METHODS OF USE THEREOF
Assignment: 1
Reel/Frame:
047740/0778Recorded: 12/11/2018Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
12/08/2018
Exec Dt:
06/20/2017
Exec Dt:
10/23/2018
Assignee:
1300 MORRIS PARK AVENUE
BRONX, NEW YORK 10461
Correspondent:
AMSTER, ROTHSTEIN & EBENSTEIN LLP
90 PARK AVENUE
NEW YORK, NY 10016
Assignment: 2
Reel/Frame:
048438/0275Recorded: 02/26/2019Pages: 16
Conveyance:
MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
01/01/2019
Newly Merged Entity Data
Exec Dt:
01/01/2019
Newly Merged Entity's New Name:
1300 MORRIS PARK AVENUE
BRONX, NEW YORK 10461
Correspondent:
AMSTER ROTHSTEIN & EBENSTEIN LLP
90 PARK AVENUE
NEW YORK, NY 10016
Assignment: 3
Reel/Frame:
048438/0275Recorded: 02/26/2019Pages: 16
Conveyance:
MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
01/01/2019
Newly Merged Entity Data
Exec Dt:
01/01/2019
Newly Merged Entity's New Name:
1300 MORRIS PARK AVENUE
BRONX, NEW YORK 10461
Correspondent:
AMSTER ROTHSTEIN & EBENSTEIN LLP
90 PARK AVENUE
NEW YORK, NY 10016

Search Results as of: 05/22/2024 01:50 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT